Table 2 Logistic regression analyses for development of no-reflow phenomenon
Variable | Univariate regression | Multiple regression | ||
|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
Age (years) | 1.010 (0.995–1.025) | 0.181 | ||
Male, n (%) | 0.795 (0.499–1.265) | 0.333 | ||
Smoking, n (%) | 0.691 (0.475–1.006) | 0.054 | ||
Heart failure (Killip II–IV, class), n (%) | 1.774 (1.203–2.614) | 0.004 | 1.381 (0.903–2.112) | 0.137 |
Hypertension, n (%) | 1.887 (1.272–2.797) | 0.002 | 1.432 (0.936–2.191) | 0.098 |
Diabetes mellitus, n (%) | 2.256 (1.555–3.272) | < 0.001 | 2.173 (1.463–3.227) | < 0.001 |
Stroke or TIA, n (%) | 1.067 (0.583–1.954) | 0.833 | ||
Family history, n (%) | 1.023 (0.407–2.571) | 0.962 | ||
Peripheral vascular history, n (%) | 5.168 (2.294–11.644) | < 0.001 | 3.448 (1.412–8.421) | 0.007 |
Hyperlipidaemia, n (%) | 0.739 (0.512–1.068) | 0.107 | ||
SBP, mmHg | 1.009 (1.001–1.017) | 0.031 | 1.007 (0.999–1.016) | 0.100 |
LVEF (%) | 0.990 (0.972–1.010) | 0.327 | ||
TC (mmol/L) | 1.052 (0.889–1.245) | 0.556 | ||
TG (mmol/L) | 0.889 (0.758–1.041) | 0.144 | ||
hs‐CRP (mg/L) | 1.004 (1.000–1.008) | 0.052 | ||
CK-MB (U/L) | 1.000 (0.999–1.001) | 0.939 | ||
UA (μmol/L) | 1.001 (0.999–1.002) | 0.464 | ||
MELD-XI score | 1.276 (1.176–1.385) | < 0.001 | 1.247 (1.144–1.360) | < 0.001 |